Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, whereas visceral adipose tissue PTX3 gene expression is increased in obesity.

@article{OsorioConles2011PlasmaPP,
  title={Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, whereas visceral adipose tissue PTX3 gene expression is increased in obesity.},
  author={{\'O}scar Osorio-Conles and Mar{\'i}a E. Guitart and Matilde R. Chac{\'o}n and Elsa Maymo-Masip and Jos{\'e} Mar{\'i}a Moreno-Navarrete and Marta Montori-Grau and Silvia N{\"a}f and J. M. Fernandez-Real and Joan Josep Vendrell and Anna Mar{\'i}a G{\'o}mez-Foix},
  journal={American journal of physiology. Endocrinology and metabolism},
  year={2011},
  volume={301 6},
  pages={
          E1254-61
        }
}
Plasma acutephase protein pentraxin 3 (PTX3) concentration is dysregulated in human obesity and metabolic syndrome. Here, we explore its relationship with insulin secretion and sensitivity, obesity markers, and adipose tissue PTX3 gene expression. Plasma PTX3 protein levels were analyzed in a cohort composed of 27 lean [body mass index (BMI) ≤ 25 kg/m(2)] and 48 overweight (BMI 25-30 kg/m(2)) men (cohort 1). In this cohort, plasma PTX3 was negatively correlated with fasting triglyceride levels… 
View on PubMed
ajpendo.physiology.org
56 Citations
Highly Influential Citations
4
Background Citations
25
Results Citations
7

56 Citations

Citation Type

Citation Type

Adipose Tissue and Serum CCDC80 in Obesity and Its Association with Related Metabolic Disease
TLDR
It is suggested for the first time that CCDC80 may be a component of the obesity-altered secretome in VAT and could act as an adipokine whose circulant levels are linked to glucose tolerance derangements and related to inflammation-associated chronic complications.
Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome
TLDR
Obesity is associated with low circulating PTX3 in ACS and this association is also observed in the presence of abdominal fat accumulation as reflected by elevated waist circumference.
Gastric bypass-induced weight loss alters obesity-associated patterns of plasma pentraxin-3 and systemic inflammatory markers.
Elevated Circulating Levels and Tissue Expression of Pentraxin 3 in Uremia: A Reflection of Endothelial Dysfunction
TLDR
Fat PTX3 mRNA levels are associated with measures of endothelial cell function in patients with CKD and may be involved in adipose tissue-orchestrated mechanisms that are restricted to the uremic milieu and modify inflammation and vascular complications in CKD patients.
Pentraxin 3 Production in the Adipose Tissue and the Skeletal Muscle in Diabetic-Obese Mice
TLDR
It is suggested that PTX3 may play a part of role as promoting insulin sensitivity of skeletal muscle in TSOD mice.
Pentraxin 3 deficiency protects from the metabolic inflammation associated to diet-induced obesity.
TLDR
The results support a critical role for PTX3 in the onset of obesity by promoting inflammation and limiting adipose tissue vascularization and delineatePTX3 targeting as a valuable strategy for the treatment of adipOSE tissue-associated inflammatory response.
Association of plasma pentraxin 3 with arterial stiffness in overweight and obese individuals.
TLDR
Arterial stiffness is increased in overweight and obese individuals and the increase in arterial stiffness may, at least in part, be associated with an obesity-related reduction in plasma PTX3 concentrations.
Association of pentraxin 3 with insulin resistance and glucose response following maximal aerobic exercise in obese and normal-mass individuals.
TLDR
The findings suggest that PTX3 could serve as a biomarker for both metabolic health, as well as a measurement to monitor the effectiveness of exercise interventions in obesity.
Pentraxin 3 Levels in Young Women with and without Polycystic Ovary Syndrome (PCOS) in relation to the Nutritional Status and Systemic Inflammation
TLDR
The results show that the decrease in PTX3 levels observed in obese is distorted in PCOS by microinflammation, and possibly, dysfunction of stroma adipose tissue and liver steatosis is reflected by enhanced insulin resistance.
Pentraxin 3 deficiency exacerbates lipopolysaccharide-induced inflammation in adipose tissue
TLDR
A protective role is suggested in LPS- and HFD-induced sustained inflammation in adipose tissue and serum PTX3 were markedly increased in response to LPS administration.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 49 REFERENCES
Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors.
Human serum levels of fetal antigen 1 (FA1/Dlk1) increase with obesity, are negatively associated with insulin sensitivity and modulate inflammation in vitro
TLDR
FA1 serum levels were increased in obese subjects and might influence Si, and the stimulatory effect of FA1 protein on pro-inflammatory cytokines on both immune and adipose cell types could contribute to worsening the inflammatory environment observed in obesity.
Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.
TLDR
A role for the abnormal regulation of this cytokine in the pathogenesis of obesity-related insulin resistance is suggested as well as the effects of weight reduction by dietary treatment of obesity on the adipose expression of TNF-alpha mRNA.
Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation
TLDR
It is shown that adipose tissue of obese mice is hypoxic and that local adipose tissues hypoxia dysregulates the production of adipocytokines, and the results suggest that hypoperfusion and Hypoxia in adipose organs underlie the dysregulated production of fat-derived secretory factors and metabolic syndrome in obesity.
The Relationship Between Serum Pentraxin 3 and Central Obesity in ST-Segment Elevation Myocardial Infarction Patients
TLDR
FAT-CT-estimated visceral fat area is the most reliable factor associated with serum PTX3 levels in patients with STEMI and central obesity.
Reciprocal Contribution of Pentraxin 3 and C‐Reactive Protein to Obesity and Metabolic Syndrome
TLDR
Levels of PTX3 and CRP antagonistically participate in the development of obesity or MetS as well as CRP were significantly higher and lower in individuals who had more than one MetS component compared with those who had none.
Complement Factor H Is Expressed in Adipose Tissue in Association With Insulin Resistance
TLDR
Increased circulating fH and fB concentrations in subjects with altered glucose tolerance could reflect increased SVC-induced activation of the alternative pathway of complement in omental adipose tissue linked to insulin resistance and metabolic disturbances.
Protein metabolism in obesity: effects of body fat distribution and hyperinsulinemia on leucine turnover.
TLDR
It is concluded that moderate obesity is associated with increased proteolysis and that insulin's antiproteolytic actions are impaired in upper-body obesity.
Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile
TLDR
It is demonstrated that PTX3, a novel marker of vascular disease, is higher in patients with metabolic syndrome associated with subclinical atherosclerosis, andPTX3 is significantly independently correlated with low HDL cholesterol, but not with cIMT, suggesting a novel association between PTx3 and atherogenic lipid profile.
Adipose inflammation, insulin resistance, and cardiovascular disease.
TLDR
Developing therapeutic strategies that target both adipose inflammation and insulin resistance may help to prevent type 2 diabetes and cardiovascular disease in the emerging epidemic of obesity.
...
1
2
3
4
5
...